ABVC BioPharma Inc. (ABVC)
0.80
-0.11 (-12.52%)
At close: Apr 04, 2025, 11:02 AM
-12.52% (1D)
| Bid | 0.64 |
| Market Cap | 10.35M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | -0.81 |
| PE Ratio (ttm) | -0.99 |
| Forward PE | -1.22 |
| Analyst | n/a |
| Ask | 1.02 |
| Volume | 89,292 |
| Avg. Volume (20D) | 566,498 |
| Open | 0.88 |
| Previous Close | 0.91 |
| Day's Range | 0.78 - 0.85 |
| 52-Week Range | 0.40 - 1.73 |
| Beta | 0.33 |
About ABVC
ABVC BioPharma, Inc., a clinical stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase I/II clinical trials a combination therapy for triple negative breast cancer; ABV-1504 has completed Phase II clinical trials for major depressive disorders; ABV-1505, which is in Phase II clinical trials for attention deficit hyperactivity d...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 10, 2004
Employees 16
Stock Exchange NASDAQ
Ticker Symbol ABVC
Website https://www.abvcpharma.com
